Akèy › Kansè pwostat rezistan a kastasyon › New Jersey
Etid klinik pou Kansè pwostat rezistan a kastasyon nan New Jersey
4 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan New Jersey.
Tèks ofisyèl etid la (Anglè)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Astera Cancer Care, East Brunswick
- Rutgers Cancer Institute of New Jersey, New Brunswick
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START New Jersey, East Brunswick
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07719361A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan
- Novartis, East Hanover
Ap rekriteEtid obsèvasyon
Laj 18 a 115 · Gason · Mizajou Jul 16, 2026 · NCT07677267A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
- Novartis, East Hanover
Ap rekriteEtid obsèvasyon
Laj 18 a 115 · Gason · Mizajou Jul 16, 2026 · NCT07677254Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.